Koelink Cecile J L, Jonkman Marcel F, Van Der Meer Klaas, Van Der Heide Wouter K
Department of General Practice.
Department of Dermatology, University Medical Center Groningen, University of Groningen, PO Box 196 9700 AD Groningen, the Netherlands.
Eur J Dermatol. 2014 May-Jun;24(3):297-304. doi: 10.1684/ejd.2014.2275.
While skin cancer incidence is rising throughout Europe, general practitioners (GP) feel unsure about their ability to diagnose skin malignancies. Objectives To evaluate whether the GP has sufficient validated clinical decision aids and tools for the examination of potentially malignant skin lesions.
We conducted a review searching Medline and the Cochrane Library. In addition, reference lists and personal archives were examined. Outcome measures were sensitivity and specificity but also the advantages and disadvantages of different clinical decision aids and tools.
No clinical decision aids or tools for the examination of non-pigmented lesions are available. Clinical decision aids and tools for the examination of pigmented lesions have mostly been studied in secondary care and, in primary care, randomised clinical trials comparing the additional value of a clinical decision aid or tools to care are scarce.
Sufficiently validated clinical decision aids and tools for the examination of potentially malignant skin lesions are lacking in general practice. The clinical decision aids and tools available in primary care need to be studied.
虽然整个欧洲皮肤癌的发病率都在上升,但全科医生(GP)对自己诊断皮肤恶性肿瘤的能力感到不确定。目的:评估全科医生是否拥有足够的经过验证的临床决策辅助工具和手段来检查潜在的恶性皮肤病变。
我们通过检索Medline和Cochrane图书馆进行了一项综述。此外,还查阅了参考文献列表和个人档案。结果指标包括敏感性和特异性,以及不同临床决策辅助工具和手段的优缺点。
目前没有用于检查非色素性病变的临床决策辅助工具或手段。用于检查色素性病变的临床决策辅助工具和手段大多是在二级医疗中进行研究的,而在初级医疗中,比较临床决策辅助工具或手段与常规护理附加价值的随机临床试验很少。
全科医疗中缺乏经过充分验证的用于检查潜在恶性皮肤病变的临床决策辅助工具和手段。初级医疗中现有的临床决策辅助工具和手段需要进行研究。